Daiwa Securities Group Inc. Agios Pharmaceuticals, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 204 shares of AGIO stock, worth $11,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204
Previous 204
-0.0%
Holding current value
$11,301
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AGIO
# of Institutions
234Shares Held
58MCall Options Held
395KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$314 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$307 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$269 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$207 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$157 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.04B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...